Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.

Pierre Kory

From Wikispooks
(Redirected from Dr. Pierre Kory)
Jump to navigation Jump to search

"COVID-19/Dissident"
Person.png Pierre Kory   Campfire Wiki LinkedIn Substack Telegram TwitterRdf-entity.pngRdf-icon.png
(doctor)
PierreKory.jpg
Alma materSt. George's University
Interestsivermectin
Founding member of the Front Line COVID-19 Critical Care Alliance. Promoter of ivermectin.

Dr Pierre Kory is a founding member of the Front Line COVID-19 Critical Care Alliance.[1] He is particularly known for his promoting of the drug ivermectin for treating "Covid".[2]

Activities

He was in New York in April 2020, working in hospitals[3]

On December 8, 2020, Kory gave testimony at the Homeland Security Committee Meeting on behalf of the FLCCC, discussing their treatment protocol, and urging early ambulatory care for COVID-19 patients.[4]

On September 27, 2021, Kory addressed Republican members of Congress on evidence of ivermectin's efficacy in treating COVID-19.[5]

During 2023, Kory published a number of op-eds in corporate media outlets attempting to incrementally expand the range of counternarratives considered acceptable for publication regarding Covid. The first op-ed, published in August 2023 by USA Today[6], addressed the unexplained increase in excess deaths in 2021 — without mentioning the Covid jabs. He later managed to get published in Newsweek[7], The Hill, TrialSite News[8] and The Washington Times.[9]

American Board of Internal Medicine

In August 2024, the American Board of Internal Medicine revoked the certifications of Pierre Kory and Paul Marik for continuing to promote ivermectin.[10]


 

A Quote by Pierre Kory

PageQuoteDate
Ivermectin“I want to bring attention to two critical deficits in our national treatment response that has made this hearing necessary in the first place. Besides the early interest and research into hydroxychloroquine, we can find no other significant efforts to research the use of any other already existing, safe, low-cost therapeutic agents. Seemingly the only research and treatment focus that we have observed on a national scale is with novel or high-cost pharmaceutically engineered products”December 2020
Many thanks to our Patrons who cover ~2/3 of our hosting bill. Please join them if you can.


References